Exact Sciences
EXAS
#1179
Rank
C$26.45 B
Marketcap
C$139.32
Share price
0.04%
Change (1 day)
71.56%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): C-$7.63

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is C-$7.24. In 2024 the company made an earnings per share (EPS) of C-$7.58.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$7.630.64%
2024C-$7.58
2022C-$4.822.31%
2021C-$4.71-38.54%
2020C-$7.66692.96%
2019C-$0.97-50.69%
2018C-$1.9644%
2017C-$1.36-39.39%
2016C-$2.25-2.94%
2015C-$2.3137.1%
2014C-$1.6979.71%
2013C-$0.94-21.59%
2012C-$1.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
C$5.04-169.66%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
C$0.53-107.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
C$0.46-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
C-$5.89-18.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
C-$69.29 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA